Dyne Therapeutics, Inc. (DYN) › Shareholders' EquityDyne Therapeutics, Inc. (DYN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$4.88M2019: $14.04M2020: $342.37M2021: $368.20M2022: $252.36M2023: $91.29M2024: $629.84M2025: $972.13M$972.13M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$972.13M+54.3%2024$629.84M+589.9%2023$91.29M-63.8%2022$252.36M-31.5%2021$368.20M+7.5%2020$342.37M+2339.2%2019$14.04M+387.7%2018-$4.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share